- Home
- COLL vs MOMO Comparison
COLL vs MOMO Comparison
Compare COLL & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- MOMO
- Stock Information
- Founded
- COLL 2002
- MOMO 2011
- Country
- COLL United States
- MOMO China
- Employees
- COLL N/A
- MOMO N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- MOMO Computer Software: Prepackaged Software
- Sector
- COLL Health Care
- MOMO Technology
- Exchange
- COLL Nasdaq
- MOMO Nasdaq
- Market Cap
- COLL 1.1B
- MOMO 1.2B
- IPO Year
- COLL 2015
- MOMO 2014
- Fundamental
- Price
- COLL $31.09
- MOMO $7.47
- Analyst Decision
- COLL Strong Buy
- MOMO Buy
- Analyst Count
- COLL 6
- MOMO 3
- Target Price
- COLL $42.00
- MOMO $8.67
- AVG Volume (30 Days)
- COLL 439.3K
- MOMO 1.2M
- Earning Date
- COLL 11-07-2024
- MOMO 12-09-2024
- Dividend Yield
- COLL N/A
- MOMO 7.07%
- EPS Growth
- COLL 757.11
- MOMO N/A
- EPS
- COLL 2.16
- MOMO 0.98
- Revenue
- COLL $599,245,000.00
- MOMO $1,558,116,328.00
- Revenue This Year
- COLL $13.20
- MOMO N/A
- Revenue Next Year
- COLL $17.63
- MOMO N/A
- P/E Ratio
- COLL $14.32
- MOMO $7.61
- Revenue Growth
- COLL 9.62
- MOMO N/A
- 52 Week Low
- COLL $28.97
- MOMO $4.79
- 52 Week High
- COLL $42.29
- MOMO $8.19
- Technical
- Relative Strength Index (RSI)
- COLL 48.70
- MOMO 58.97
- Support Level
- COLL $29.67
- MOMO $7.40
- Resistance Level
- COLL $31.10
- MOMO $7.85
- Average True Range (ATR)
- COLL 0.98
- MOMO 0.29
- MACD
- COLL 0.26
- MOMO 0.08
- Stochastic Oscillator
- COLL 69.41
- MOMO 71.71
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines out of which Momo's service lines segment derives the majority of revenue.